| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/20/2002 | EP1180765A1 Optical recording medium and porphycene compound |
| 02/20/2002 | EP1180126A1 Subphthalocyanine colorants, ink compositions and methods of making the same |
| 02/20/2002 | EP1180028A1 Il-8 receptor antagonists |
| 02/20/2002 | EP0909182B1 Method for producing chlorins and bacteriochlorins containing polyether |
| 02/20/2002 | EP0668763B1 Use of phenserine for the preparation of medicaments for the treatment of cognitive disorders |
| 02/20/2002 | CN1336928A Cytotoxic alkaloid derivatives including asmarine A and B isolated from a sponge |
| 02/20/2002 | CN1336375A Spiro-and dicyclic diazine and carbozine oxazolidohne compound |
| 02/19/2002 | US6348474 Compounds as antidiabetic agents |
| 02/19/2002 | US6348466 CRF receptor antagonists and methods relating thereto |
| 02/19/2002 | US6348456 Method of treating chemical dependency in mammals and a composition therefor |
| 02/19/2002 | US6348454 Bactericide antibiotics |
| 02/18/2002 | CA2354653A1 Peptide mutant of human erab/hadh2, its x-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 02/14/2002 | WO2002070513A1 Methods for the preparation of mirtazapine intermediates |
| 02/14/2002 | WO2002012442A2 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | WO2002012246A1 Pyrrolotriazolopyrimidinone derivatives |
| 02/14/2002 | WO2002012245A2 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | WO2002012244A2 Polymorphs of zaleplon and methods for the preparation thereof |
| 02/14/2002 | WO2002012243A2 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE |
| 02/14/2002 | WO2002012242A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/14/2002 | WO2002012241A1 Compounds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated diseases or dysfunction |
| 02/14/2002 | WO2002012239A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | WO2002012236A1 Substituted triazolopyrid(az)ines as plant treatment agents (herbicides) |
| 02/14/2002 | WO2002012230A1 Intermediate of carbapenem antibiotics and process for the preparation thereof |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002011732A1 Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists |
| 02/14/2002 | WO2002011731A2 Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches |
| 02/14/2002 | WO2002011670A2 Solid forms of tin ethyl etiopurpurin and processes for producing such forms |
| 02/14/2002 | WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2002 | WO2000043395A8 Substituted porphyrins |
| 02/14/2002 | US20020019526 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/14/2002 | US20020019525 Pyrido [2,3-b] indolizine derivatives and aza analogues thereof; CRF1 specific ligands |
| 02/14/2002 | US20020019523 Dietetics; antidabetic agents; sexual disrders |
| 02/14/2002 | US20020019429 Antiarthritic agents; osteoporosis |
| 02/14/2002 | US20020019410 Central nervous system disorders |
| 02/14/2002 | US20020019406 9H-pyrimido[4,5-b]indole derivatives: CRF1 specific ligands |
| 02/14/2002 | US20020019405 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 02/14/2002 | US20020019398 Methods of making and using N-desmethylzopiclone |
| 02/14/2002 | US20020019388 (cis)-6-(3-pyridinyl)-3,6-diazabicyclo(3.2.0) heptane for example; Alzheimer's disease, Parkinson's disease, attention deficit hyperactivity disorder, depression, nicotinic withdrawal syndrome, Tourette's syndrome, and schizophrenia |
| 02/14/2002 | US20020018973 Coupler and silver halide color photographic light-sensitive material |
| 02/14/2002 | US20020017297 Dry powder dispersing apparatus and methods for their use |
| 02/14/2002 | DE10038019A1 Substituierte Triazolopyrid(az)ine Substituted Triazolopyrid (az) ine |
| 02/14/2002 | CA2504880A1 Polymorphs of zaleplon and methods for the preparation thereof |
| 02/14/2002 | CA2438446A1 Methods for the preparation of mirtazapine intermediates |
| 02/14/2002 | CA2420967A1 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | CA2417967A1 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | CA2417784A1 Pyrrolotriazolopyrimidinone derivatives |
| 02/14/2002 | CA2417783A1 Solid forms of tin ethyl etiopurpurin and processes for producing such forms |
| 02/14/2002 | CA2416906A1 Synthesis of (r)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo[1,2-a]imidazol-2-one |
| 02/14/2002 | CA2412368A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/13/2002 | EP1178993A1 Thiazoloderiatives and pharmaceutical compositions containing them |
| 02/13/2002 | EP1178990A1 Imidazodiazepine derivative |
| 02/13/2002 | EP1178989A1 Process for making fused-ring imidazo-containing compounds |
| 02/13/2002 | EP1178987A1 Substituted benzoylisoxazoles and the use thereof as herbicides |
| 02/13/2002 | EP1178805A1 Novel synthesis and crystallization of piperazine ring-containing compounds |
| 02/13/2002 | EP1178784A1 New pharmaceutical combinations for nos inhibitors |
| 02/13/2002 | EP1049695B1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 02/13/2002 | EP0968253B1 Fluorescent host-guest-system |
| 02/13/2002 | EP0946561B1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments |
| 02/13/2002 | EP0861250B1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 02/13/2002 | CN1335850A Quinoline derivatives |
| 02/13/2002 | CN1335849A Pyrrolopyrimidines as protein kinase inhibitors |
| 02/13/2002 | CN1335317A Process for producing pyrazolo [4,3-d] pyrimidine-7-ketonic compound and its intermediate |
| 02/13/2002 | CN1335301A 3-cyano-2,4,5-trifluoro-benzoic acid and its derivant and their application |
| 02/13/2002 | CN1079097C Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 02/12/2002 | US6346534 Imidazolo(1,2-a)- or pyrrolo(1,2-a)-pyrimidone derivatives; anticarcinogenic agents; benign prostatic hyperplasia; sexual, glandular, sleep and urogenital disorders; endometriosis, irritable bowel syndrome |
| 02/12/2002 | US6346531 G-CSF mimetics |
| 02/12/2002 | US6346526 Carbapenicillin with 1,1-dioxo-2,3-dihydronaphtho(1,8-de)(1,2)thiazin-2-yl-substituent; treating staphylococcus infections resistant to methicillin; side effect reduction |
| 02/12/2002 | US6346359 Pyrrolopyrimidineone compound and heat-sensitive recording material using the same |
| 02/07/2002 | WO2002010173A1 Dihydroporphyrin derivatives and their uses |
| 02/07/2002 | WO2002010172A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 02/07/2002 | WO2002010171A1 Crystalline therapeutic agent |
| 02/07/2002 | WO2002010170A1 Imidazo-pyrazine derivatives as ligands for gaba receptors |
| 02/07/2002 | WO2002010169A1 Piperazine derivatives |
| 02/07/2002 | WO2002010168A1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 02/07/2002 | WO2002010163A1 Process for preparing azacycloalkanoylaminothiazoles |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2001062744A3 Substituted piperazine compounds |
| 02/07/2002 | US20020016498 Jet streams of solvent impinge creating high turbulence at point of impact on chemical intermediates; eliminates need for high intensity milling |
| 02/07/2002 | US20020016366 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof |
| 02/07/2002 | US20020016352 Cancer treatment with Go6976 and its related compounds |
| 02/07/2002 | US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha |
| 02/07/2002 | US20020016333 Pyrazoles and pyrazolopyrimidines having crf antagonistic activity |
| 02/07/2002 | US20020016328 Corticotropin releasing factor antagonists |
| 02/07/2002 | US20020016327 Compounds and methods of use for treatment of neurogenic inflammation |
| 02/07/2002 | CA2417260A1 Process for preparing azacycloalkanoylaminothiazoles |
| 02/07/2002 | CA2417204A1 Imidazolyl derivatives |
| 02/07/2002 | CA2417121A1 Imidazo-pyrazine derivatives as ligands for gaba receptors |
| 02/07/2002 | CA2416523A1 Dihydroporphyrin derivatives and their uses |
| 02/06/2002 | EP1178048A1 Azabicycloalkane derivatives for use as serotonin reuptake inhibitors and 5HT2a antagonists |
| 02/06/2002 | EP1178047A1 Diazabicyclooctane derivatives and therapeutic uses thereof |
| 02/06/2002 | EP1177795A2 Use of ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP1177196A1 Heteroaryl diazabicycloalkanes, their preparation and use |
| 02/06/2002 | EP1177195A1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/06/2002 | EP1177177A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/06/2002 | EP1176959A1 Novel prolines as antimicrobial agents |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/06/2002 | EP0836605B1 Pyrrolopyrimidines and processes for the preparation thereof |